US Federal 2025-2026 Regular Session

US Federal House Bill HB5278

Introduced
 
Introduced
9/10/25  

Caption

Affordable Inhalers and Nebulizers Act of 2025

Impact

The implications of HB 5278 include significant changes to health insurance coverage relating to specified inhaler products. By ensuring that cost-sharing requirements for these products are limited, the bill could alleviate financial burdens on patients and promote better adherence to prescribed treatment regimens. As a result, it is expected that health outcomes in populations affected by asthma and COPD could improve, leading to reduced hospital visits and healthcare costs in the long term.

Summary

House Bill 5278, known as the Affordable Inhalers and Nebulizers Act of 2025, aims to reduce patient cost-sharing for specified inhaler products used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The bill mandates that patients will not be required to pay a deductible for these inhalers, and the maximum co-payment for a 30-day supply will not exceed $15. This initiative is designed to improve access to essential medications for individuals suffering from these conditions, particularly those at a financial disadvantage.

Contention

While the provisions of the bill are largely aimed at enhancing patient access and reducing costs, there may be points of contention surrounding the implementation and potential financial impacts on insurance providers and healthcare systems. Critics may argue that limiting cost-sharing could lead to increased premiums or impose financial strains on health plans, particularly if a significant uptick in inhaler prescriptions occurs. The debate may center on how to balance the interests of patients needing affordable medication with the financial sustainability of health insurance systems.

Companion Bills

US SB2756

Related Affordable Inhalers and Nebulizers Act of 2025

Previously Filed As

US SB2756

Affordable Inhalers and Nebulizers Act of 2025

US H2526

Relative to the provision and administration of bronchodilators, spacers, and nebulizers in schools

US SB1347

An act to amend Section 49414.7 to of the Education Code, and to add Section 4119.21 to the Business and Professions Code, relating to pupil health.

US S291

Reduces copayments and coinsurance for asthma inhalers covered by certain health benefits plans.

US A453

Reduces copayments and coinsurance for asthma inhalers covered by certain health benefits plans.

US HB0760

AN ACT to amend Tennessee Code Annotated, Title 49; Title 53; Title 63 and Title 68, relative to bronchodilator rescue inhalers.

US SB0817

AN ACT to amend Tennessee Code Annotated, Title 49; Title 53; Title 63 and Title 68, relative to bronchodilator rescue inhalers.

US HB399

Revise prior authorization laws

US HB2117

In school health services, further providing for definitions, for possession and use of asthma inhalers and epinephrine auto-injectors, for school access to emergency epinephrine and for administration of epinephrine auto-injectors by school bus drivers and school crossing guards.

US HB245

Breath of Fresh Air Act This bill establishes a grant program for local educational agencies to purchase, and train school personnel to use, nebulizers.

Similar Bills

No similar bills found.